Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Gujarat Themis Biosyn Limited as of 30 June 2025 is 1,478.45 MM.
- The operating income for Gujarat Themis Biosyn Limited as of 30 June 2025 is 579.55 MM.
- The net income for Gujarat Themis Biosyn Limited as of 30 June 2025 is 445.97 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,478.45 | 579.55 | 445.97 |
2025-03-31 | 1,508.00 | 643.33 | 487.72 |
2024-12-31 | 1,550.75 | 686.63 | 526.59 |
2024-09-30 | 1,543.32 | 680.50 | 527.01 |
2024-06-30 | 1,590.61 | 698.41 | 546.78 |
2024-03-31 | 1,698.22 | 751.98 | 591.63 |
2023-12-31 | 1,562.73 | 704.65 | 549.70 |
2023-09-30 | 1,455.79 | 651.50 | 517.65 |
2023-06-30 | 1,530.29 | 724.73 | 579.20 |
2023-03-31 | 1,489.73 | 724.88 | 579.69 |
2022-12-31 | 1,495.64 | 707.41 | 560.66 |
2022-09-30 | 1,400.02 | 685.23 | 533.79 |
2022-06-30 | 1,273.58 | 618.39 | 484.72 |
2022-03-31 | 1,148.54 | 565.33 | 436.24 |
2021-12-31 | 1,093.89 | 519.84 | 396.26 |
2021-09-30 | 1,151.89 | 530.68 | 399.76 |
2021-06-30 | 1,073.40 | 485.27 | 375.30 |
2021-03-31 | 905.63 | 396.70 | 301.80 |
2020-12-31 | 936.17 | 438.66 | 353.41 |
2020-09-30 | 998.13 | 481.58 | 375.78 |
Income Statement: EPS
- The earnings per share basic for Gujarat Themis Biosyn Limited as of 30 June 2025 is 4.10.
- The earnings per share diluted for Gujarat Themis Biosyn Limited as of 30 June 2025 is 4.10.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | 4.10 | 4.10 |
2025-03-31 | 4.48 | |
2024-12-31 | 4.83 | 4.83 |
2024-09-30 | 4.83 | 4.83 |
2024-06-30 | 5.02 | 5.01 |
2024-03-31 | 5.43 | |
2023-12-31 | 5.05 | 5.05 |
2023-09-30 | 4.75 | 4.75 |
2023-06-30 | 5.32 | 5.32 |
2023-03-31 | 5.32 | 5.32 |
2022-12-31 | 5.14 | 5.15 |
2022-09-30 | 4.90 | 4.90 |
2022-06-30 | 4.45 | 4.45 |
2022-03-31 | 4.00 | 4.00 |
2021-12-31 | 3.64 | 3.64 |
2021-09-30 | 3.67 | 3.67 |
2021-06-30 | 3.44 | 3.44 |
2021-03-31 | 2.77 | 2.77 |
2020-12-31 | 3.24 | 3.24 |
2020-09-30 | 3.45 | 3.45 |
Cash Flow: Operations, Investing, Financing
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | 910.29 | -1,118.18 | 260.14 |
2024-12-31 | |||
2024-09-30 | 887.78 | -744.66 | -79.57 |
2024-06-30 | |||
2024-03-31 | 642.13 | -552.12 | -85.87 |
2023-12-31 | |||
2023-09-30 | 574.86 | -467.74 | -94.61 |
2023-06-30 | |||
2023-03-31 | 395.01 | -204.08 | -132.99 |
2022-12-31 | |||
2022-09-30 | 302.00 | -183.64 | -158.66 |
2022-06-30 | |||
2022-03-31 | 403.13 | -298.32 | -139.95 |
2021-12-31 | |||
2021-09-30 | 288.19 | -227.16 | -45.41 |
2021-06-30 | |||
2021-03-31 | 105.31 | -22.52 | -51.64 |
2020-12-31 | |||
2020-09-30 | 97.34 | -15.30 | -65.19 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Gujarat Themis Biosyn Limited as of 30 June 2025 is 78.08.
- The p/book for Gujarat Themis Biosyn Limited as of 30 June 2025 is 15.33.
- The p/tbv for Gujarat Themis Biosyn Limited as of 30 June 2025 is 15.34.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 78.08 | 15.33 | 15.34 |
2025-03-31 | 61.56 | 14.51 | 14.52 |
2024-12-31 | 45.40 | 10.70 | 10.71 |
2024-09-30 | 45.36 | 10.70 | 10.71 |
2024-06-30 | 65.45 | 19.23 | 19.23 |
2024-03-31 | 70.69 | 21.83 | 21.83 |
2023-12-31 | 74.80 | 21.75 | 21.75 |
2023-09-30 | 66.84 | 25.96 | 25.96 |
2023-06-30 | 41.28 | 16.03 | 16.03 |
2023-03-31 | 41.24 | 16.03 | 16.03 |
2022-12-31 | 72.54 | 28.91 | 28.91 |
2022-09-30 | 44.79 | 17.85 | 17.85 |
2022-06-30 | 49.32 | 23.14 | 23.14 |
2022-03-31 | 54.80 | 23.14 | 23.14 |
2021-12-31 | 60.33 | 24.74 | 24.74 |
2021-09-30 | 59.80 | 24.74 | 24.74 |
2021-06-30 | 63.70 | 34.18 | 34.18 |
2021-03-31 | 79.22 | 34.18 | 34.18 |
2020-12-31 | 67.65 | 42.15 | 42.15 |
2020-09-30 | 63.62 | 42.15 | 42.15 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.02.
- The ebit (3y)/ev for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.02.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.02 | 0.02 |
2025-03-31 | 0.02 | 0.02 |
2024-12-31 | 0.03 | 0.03 |
2024-09-30 | 0.03 | 0.03 |
2024-06-30 | 0.02 | 0.02 |
2024-03-31 | 0.02 | 0.02 |
2023-12-31 | 0.02 | 0.02 |
2023-09-30 | 0.02 | 0.02 |
2023-06-30 | 0.03 | 0.03 |
2023-03-31 | 0.03 | 0.02 |
2022-12-31 | 0.02 | 0.02 |
2022-09-30 | 0.03 | 0.02 |
2022-06-30 | 0.03 | 0.02 |
2022-03-31 | 0.02 | 0.02 |
2021-12-31 | 0.02 | 0.02 |
2021-09-30 | 0.02 | 0.02 |
2021-06-30 | 0.02 | 0.01 |
2021-03-31 | 0.02 | 0.01 |
2020-12-31 | 0.02 | 0.01 |
2020-09-30 | 0.02 | 0.01 |
Management Effectiveness
- The roa for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.22.
- The roe for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.22.
- The roic for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.17.
- The croic for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.02.
- The ocroic for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.33.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.22 | 0.22 | 0.17 | 0.02 | 0.33 |
2025-03-31 | 0.27 | 0.30 | 0.23 | 0.03 | 0.39 |
2024-12-31 | 0.27 | 0.30 | 0.23 | 0.03 | 0.39 |
2024-09-30 | 0.27 | 0.30 | 0.23 | 0.03 | 0.39 |
2024-06-30 | 0.36 | 0.40 | 0.29 | 0.00 | 0.31 |
2024-03-31 | 0.34 | 0.41 | 0.30 | 0.01 | 0.32 |
2023-12-31 | 0.32 | 0.39 | 0.29 | 0.01 | 0.32 |
2023-09-30 | 0.47 | 0.56 | 0.39 | 0.04 | 0.26 |
2023-06-30 | 0.47 | 0.56 | 0.39 | 0.04 | 0.26 |
2023-03-31 | 0.47 | 0.56 | 0.39 | 0.04 | 0.26 |
2022-12-31 | 0.46 | 0.55 | 0.40 | -0.03 | 0.22 |
2022-09-30 | 0.46 | 0.55 | 0.39 | -0.03 | 0.22 |
2022-06-30 | 0.55 | 0.69 | 0.46 | -0.03 | 0.39 |
2022-03-31 | 0.49 | 0.62 | 0.42 | -0.03 | 0.39 |
2021-12-31 | 0.51 | 0.70 | 0.40 | 0.02 | 0.29 |
2021-09-30 | 0.52 | 0.70 | 0.41 | 0.02 | 0.29 |
2021-06-30 | 0.59 | 0.89 | 0.50 | 0.04 | 0.14 |
2021-03-31 | 0.47 | 0.72 | 0.40 | 0.04 | 0.14 |
2020-12-31 | 0.74 | 1.64 | 0.62 | 0.03 | 0.17 |
2020-09-30 | 0.79 | 1.74 | 0.57 | 0.03 | 0.15 |
Gross Margins
- The gross margin for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.62.
- The net margin for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.32.
- The operating margin for Gujarat Themis Biosyn Limited as of 30 June 2025 is 0.42.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.62 | 0.32 | 0.42 |
2025-03-31 | 0.61 | 0.34 | 0.44 |
2024-12-31 | 0.61 | 0.34 | 0.44 |
2024-09-30 | 0.61 | 0.34 | 0.44 |
2024-06-30 | 0.61 | 0.35 | 0.44 |
2024-03-31 | 0.61 | 0.35 | 0.45 |
2023-12-31 | 0.61 | 0.36 | 0.45 |
2023-09-30 | 0.61 | 0.38 | 0.47 |
2023-06-30 | 0.61 | 0.38 | 0.47 |
2023-03-31 | 0.62 | 0.39 | 0.48 |
2022-12-31 | 0.78 | 0.38 | 0.49 |
2022-09-30 | 0.78 | 0.38 | 0.49 |
2022-06-30 | 0.63 | 0.38 | 0.49 |
2022-03-31 | 0.64 | 0.38 | 0.49 |
2021-12-31 | 0.79 | 0.36 | 0.48 |
2021-09-30 | 0.76 | 0.35 | 0.46 |
2021-06-30 | 0.78 | 0.35 | 0.46 |
2021-03-31 | 0.81 | 0.33 | 0.44 |
2020-12-31 | 0.90 | 0.38 | 0.47 |
2020-09-30 | 0.88 | 0.38 | 0.48 |
Identifiers and Descriptors
Central Index Key (CIK) |